MedTrace Logo

A Survey to Assess Effects of Covid-19 on Cardiovascular Patients

NCT04508920 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2020-08-11

No results posted yet for this study

Summary

The design included 152 patients with confirmed heart failure (HF) evaluated in two different periods of time: a baseline before the outbreak, and other during the outbreak of which 76 patients were randomized in each group. A care and follow-up guide was used as an instrument through a face-to-face survey (baseline group) and telemedicine (group outbreak). The primary outcome was the comparison of functional class modification observed in patients

Conditions

Interventions

OTHER

Symptomatology, Treatment. daily Activities and Anxiety for Cardiovascular patients Survey (STRATA)

Interventions were recorded in two groups of patients, who were randomly selected, in two different periods of time. The basal group was intervened from 15 May to 15 June 2019, a pandemic-free period. The outbreak group from 15 May to 15 June 2020, corresponding to increased activity of contagiousness and mortality associated with COVID-19, in general population in Mexico14 Basal measurement was performed in a face to face method. In Outbreak period, under social isolation conditions, patients were evaluated by telephone. The assessments were performed out by medical staff with specialized training, with evaluations to which patients were accustomed by regular cohort assessments. The questions were ordered and systematized in a patient evaluation, care, and follow-up guide (appendix). A causality association question of emotional distress perception was added. We recorded mortality and rehospitalization

Sponsors & Collaborators

  • Instituto Nacional de Cardiologia Ignacio Chavez

    collaborator OTHER

  • Medica Sur Clinic & Foundation

    collaborator OTHER

  • Centro en Insuficiencia Cardiaca, Mexico

    lead OTHER

Principal Investigators

  • EDUARDO CHUQUIURE-VALENZUELA, MD · Centro en insuficiencia cardiaca

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2021-06-15
Completion
2021-07-15

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04508920 on ClinicalTrials.gov